Considering the short half-life of exogenous IL-15 in mice, we used the high dose of IL-15 as previous studies described (16, 17), and we found enhanced tumor growth in the 5 μg IL-15 (200 μg/kg) group (Figure S1A in Supplementary Material). The gene discussed is IL15; the disease is neoplasm.